References
- Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy. 2014;69:3–16.
- Leung D, Bieber T. Atopic dermatitis. Lancet. 2003;361:151–160.
- Tezza G, Mazzei F, Boner A. Epigenetics of allergy. Early Hum Dev. 2013;89:S20–S21.
- Gallo C, Vighi G, Schroeder J, et al. Chronic urticaria atopic dermatitis and celiac disease. Am J Gastroenterol. 1992;87:1684
- Kolkhir P, Borzova E, Grattan C, et al. Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review. Autoimmun Rev. 2017;16:1196–1208.
- Eichenfield L, Tom W, Chamlin S, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014; 70:338–351.
- Schneider L, Tilles S, Lio P, et al. Atopic dermatitis: a practice parameter update. J Allergy Clin Immunol. 2013;131:295–299.
- MacGlashan D, Bochner B, Adelman D, et al. Down-regulation of FceRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol. 1997;158:1428–1445.
- Labrador-Horrillo M, Ferrer M. Profile of omalizumab in the treatment of chronic spontaneous urticaria. Drug Des Devel Ther. 2015;2015;9:4909–4915.
- Vignola A, Humbert M, Bousquet J, et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: solar. Allergy. 2004;59:709–717.
- Leynadier F, Doudou O, Gaouar H, et al. Effect of omalizumab in health care workers with occupational latex allery. J Allergy Clin Immunol. 2004;133:360–361.
- Bantz SK, Zhu Z, Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 2014;5:202.
- Chen T, Chan S, Lack G, et al. The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): statistical analysis plan. Trials. 2017;23:18–231.
- Fernández-Antón Martínez M, Leis-Dosil V, Alfageme-Roldán F, et al. Omalizumab for the treatment of atopic dermatitis. Actas Dermosifiliogr. 2012;103:624–628.
- Holm J, Agner T, Sand C, et al. Omalizumab for atopic dermatitis: case series and a systematic review of the literature. Int J Dermatol. 2017;56:18–26.